Author: Brigham-Faulkner OB/GYN Associates

17 Million U.S. Women Face Urinary Incontinence

Approximately 17 million women between the age of 18 & 60 in the U.S. encounter urinary incontinence in their lifetime. The condition that results in loss of control in managing the flow of urine from your body is typically a result of the urethra not being closed tightly to keep the urine in the bladder.

Continue reading “17 Million U.S. Women Face Urinary Incontinence”

Be Informed On Your Treatment Options For Gynecologic Cancers

A wide variety of gynecologic cancers can affect a woman’s reproductive system, which consists of the uterus, vagina, ovaries and fallopian tubes. The most common types of gynecologic cancers are cervical, endometrial (uterine) and ovarian cancer. The specific type of cancer a woman has and how advanced it is, will determine her available treatment options.

 

Hysterectomies are often performed on women with early stage gynecologic cancer. An estimated one third of all U.S. women will have a hysterectomy by age 60.

To learn more about symptoms and treatment options for gynecologic cancers.

Five-Minute Procedure to End Heavy Periods

If you’re like 1 in 5 women with heavy periods, you want to get back to life. NovaSure® is a one- time, five-minute procedure that can lighten or end your heavy period.

 

The endometrial ablation procedure that works by removing the endometrium, or the lining of the uterus (the part that causes the bleeding), with a quick delivery of radiofrequency energy.

NovaSure first step

Your doctor slightly opens your cervix (the opening to the uterus), inserts a slender wand, and extends a triangular mesh device into the uterus
NovaSure first step

Your doctor slightly opens your cervix (the opening to the uterus), inserts a slender wand, and extends a triangular mesh device into the uterus
NovaSure first step

Precisely measured radio frequency energy is delivered through the mesh for about 90 seconds, gently removing the lining of the uterus
NovaSure first step

The mesh device is pulled back into the wand and both are removed from the uterus.

Minimally Invasive Solution to Uterine Fibroids

da Vinci ® Myomectomy

Each year, roughly 65,000 myomectomies are performed in the U.S. The conventional approach to myomectomy is open surgery, through a large abdominal incision. After cutting around and removing each uterine fibroid, the surgeon must carefully repair the uterine wall to minimize potential uterine bleeding, infection and scarring. Proper repair is also critical to reducing the risk of uterine rupture during future pregnancies.

While myomectomy is also performed laparoscopically, this approach can be challenging for the surgeon, and may compromise results compared to open surgery.  Laparoscopic myomectomies often take longer than open abdominal myomectomies, and up to 28% are converted during surgery to an open abdominal incision. Myomectomy can be a uterine-preserving alternative to open abdominal hysterectomy.

da Vinci ® Myomectomy

A new category of minimally invasive myomectomy, da Vinci ® Myomectomy, combines the best of open and laparoscopic surgery. With the assistance of the da Vinci ® Surgical System – the latest evolution in robotics technology – surgeons may remove uterine fibroids through small incisions with unmatched precision and control. Among the potential benefits of da Vinci Myomectomy as compared to traditional open abdominal surgery are:

  • Opportunity for future pregnancy
  • Significantly less pain
  • Less blood loss
  • Fewer complications
  • Less scarring
  • A shorter hospital stay
  • A faster return to normal daily activities

da Vinci ® Myomectomy is performed with the da Vinci ® Surgical System, which allows your surgeon to perform a minimally invasive, yet remarkably precise, comprehensive reconstruction of the uterine wall, regardless of the size or location of your fibroids. The unique level of control and precision provided by da Vinci ® can also help your surgeon provide the most precise and thorough reconstruction possible, helping to prevent possible uterine rupture (tearing) during future pregnancies.

As with any surgery, these benefits cannot be guaranteed, as surgery is both patient- and procedure-specific. While myomectomy performed using the da Vinci Surgical System is considered safe and effective, this procedure may not be appropriate for every individual. Always ask your doctor about all treatment options, as well as their risks and benefits.

State-of-the-art da Vinci Surgery carries big benefits in Hysterectomy procedures

The da Vinci System enables your doctor to perform a minimally invasive hysterectomy even for complex conditions — with enhanced vision, precision, dexterity and control. da Vinci Hysterectomy offers women many potential benefits over traditional surgery, including:

  • Less pain
  • Fewer complications
  • Less blood loss
  • Shorter hospital stay
  • Low risk of wound infection
  • Quicker recovery and return to normal activities

Learn why da Vinci Hysterectomy may be your best treatment option for a range of gynecologic conditions.

The use of barbed sutures in obstetrics and gynecology.

The use of barbed sutures in obstetrics and gynecology.

Rev Obstet Gynecol. 2010;3(3):82-91

Authors: Greenberg JA

Abstract
Despite the multitude of different procedures performed with a host of different wound closure biomaterials, no study or surgeon has yet identified the perfect suture for all situations. In recent years, a new class of suture material-barbed suture-has been introduced into the surgeon’s armamentarium. This review focuses on barbed suture to better understand the role of this newer material in obstetrics and gynecology.

PMID: 21364859 [PubMed] ]]>

Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy.

Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy.

J Crit Care. 2012 Feb;27(1):51-7

Authors: Greenberg JA, Lennox JL, Martin GS

Abstract
RATIONALE: With the advent of highly active antiretroviral therapy (HAART), sepsis has become a more frequent ICU diagnosis for patients with HIV infections. Yet, little is known about the etiologies of acute infections in critically ill patients with HIV and the factors that affect in-hospital mortality.
METHODS: Cases of patients with HIV requiring intensive care specifically for severe sepsis were identified over 27 months. Demographic information, variables related to acute illness severity, variables related to HIV infection, and all acute infections contributing to ICU stay were recorded.
RESULTS: Of 990 patients admitted to the ICU with severe sepsis, 136 (13.7%) were HIV-infected. There were 194 acute infections among the 125 patients with full data available; 112 of the infections were nosocomial/health care-associated, 55 were AIDS-related, and 27 were community-acquired. Patients with nosocomial/health care-associated and AIDS-related infections had lower CD4 counts and were less likely to be on HAART (P < .05). The inpatient mortality was 42%. In a multivariable logistic regression model, only the APACHE II score (odds ratio, 1.12; 95% confidence interval, 1.02-1.23) was significantly associated with hospital mortality, although any HAART use (odds ratio, 0.53; 95% confidence interval, 0.22-1.33, P = .18) approached statistical significance.
CONCLUSIONS: In this large cohort study, nosocomial/health care-associated infections were common in ICU patients with HIV and severe sepsis. Hospital mortality was associated with acute illness severity, but not clearly associated with variables related to HIV infection. Interventions that aim to prevent or more effectively treat nosocomial infections in critically ill patients with HIV may favorably impact clinical outcomes.

PMID: 22033058 [PubMed – in process] ]]>

Folic Acid supplementation and pregnancy: more than just neural tube defect prevention.

Folic Acid supplementation and pregnancy: more than just neural tube defect prevention.

Rev Obstet Gynecol. 2011;4(2):52-9

Authors: Greenberg JA, Bell SJ, Guan Y, Yu YH

Abstract
Folate (vitamin B(9)) is an essential nutrient that is required for DNA replication and as a substrate for a range of enzymatic reactions involved in amino acid synthesis and vitamin metabolism. Demands for folate increase during pregnancy because it is also required for growth and development of the fetus. Folate deficiency has been associated with abnormalities in both mothers (anemia, peripheral neuropathy) and fetuses (congenital abnormalities). This article reviews the metabolism of folic acid, the appropriate use of folic acid supplementation in pregnancy, and the potential benefits of folic acid, as well as the possible supplementation of l-methylfolate for the prevention of pregnancy-related complications other than neural tube defects.

PMID: 22102928 [PubMed] ]]>

Facebook